UBT251
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
The United Bio-Technology (Hengqin) Co · Phase 2 · Recruiting · Enrollment 333
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Part A - UBT251 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part A - placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - Arm A (UBT251) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - Arm B (UBT251) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - Arm C (UBT251) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - Arm D (UBT251) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - Arm E (UBT251) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part B - placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 3 | Obesity or overweight | n/r | n/r | n/r | n/r |